Abstract
Safety, tolerability and pharmacokinetics of a novel oral hepatitis C virus NS5A inhibitor DAG181PA Capsules in Chinese healthy volunteers
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings for Annual Meeting of The Japanese Pharmacological Society
Paper Title
Journal
Date
